Karani Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Buy |
31,125
+493
| +2% | +$34K | 2.08% | 19 |
|
|
2025
Q1 | $2.13M | Buy |
30,632
+6,844
| +29% | +$475K | 2.25% | 21 |
|
|
2024
Q4 | $2.05M | Buy |
+23,788
| New | +$2.05M | 1.91% | 21 |
|
|
2023
Q3 | $2.21M | Sell |
24,330
-25,330
| -51% | -$2.3M | 3.19% | 16 |
|
|
2023
Q2 | $4.02M | Hold |
49,660
| – | – | 4.05% | 12 |
|
|
2023
Q1 | $3.95M | Sell |
49,660
-11,684
| -19% | -$930K | 4.19% | 8 |
|
|
2022
Q4 | $4.15M | Sell |
61,344
-23,700
| -28% | -$1.6M | 4.84% | 5 |
|
|
2022
Q3 | $4.24M | Buy |
85,044
+1,230
| +1% | +$61.3K | 4.3% | 7 |
|
|
2022
Q2 | $4.67M | Sell |
83,814
-28,116
| -25% | -$1.57M | 4.32% | 10 |
|
|
2022
Q1 | $6.22M | Buy |
111,930
+13,810
| +14% | +$767K | 3.36% | 14 |
|
|
2021
Q4 | $5.5M | Buy |
98,120
+236
| +0.2% | +$13.2K | 2.72% | 20 |
|
|
2021
Q3 | $4.7M | Buy |
97,884
+1,460
| +2% | +$70.1K | 2.28% | 23 |
|
|
2021
Q2 | $4.04M | Buy |
96,424
+638
| +0.7% | +$26.7K | 2.09% | 23 |
|
|
2021
Q1 | $3.23M | Buy |
95,786
+3,056
| +3% | +$103K | 1.9% | 25 |
|
|
2020
Q4 | $3.24M | Sell |
92,730
-13,300
| -13% | -$465K | 1.92% | 25 |
|
|
2020
Q3 | $3.68M | Hold |
106,030
| – | – | 2.47% | 21 |
|
|
2020
Q2 | $3.47M | Sell |
106,030
-8,100
| -7% | -$265K | 2.69% | 18 |
|
|
2020
Q1 | $3.44M | Buy |
114,130
+31,330
| +38% | +$943K | 3.67% | 12 |
|
|
2019
Q4 | $2.4M | Buy |
+82,800
| New | +$2.4M | 2.22% | 16 |
|